{"id":4192,"date":"2015-03-24T14:47:59","date_gmt":"2015-03-24T18:47:59","guid":{"rendered":"https:\/\/globalhealthintelligence.com\/?p=708"},"modified":"2025-12-01T13:23:47","modified_gmt":"2025-12-01T19:23:47","slug":"708","status":"publish","type":"post","link":"https:\/\/globalhealthintelligence.com\/es\/news\/708\/","title":{"rendered":"Medtronic to begin drug-filled stent clinical trial in Australia and Brazil"},"content":{"rendered":"<p>Medtronic is planning to start the drug-filled stent (DFS) trial at several sites in Australia and Brazil. The strategic decision is based on the results of the stent\u2019s preclinical studies, in which DFS exhibited a controlled and efficacious drug release into the arterial wall without a polymer carrier, along with reduced stenosis and inflammation. 100 patients will be enrolled for the trial to evaluate late lumen loss. The device has a tri-layer wire design, which helps to remove the innermost layer and the drug is released from the core upon the stent surface through albuminal side holes, leading to the polymer-free drug release during the required interval of time. The new DFS stands on the platform of Resolute Integrity DES with Continuous Sinusoid Technology and the Resolute Onyx DES with CoreWire Technology.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On back of the results of preclinical studies of the new the drug-filled stent (DFS), Medtronic is planning to start its clinical trials in Australia and Brazil. The company plans to enroll 100 patients to assess late lumen loss. The new DFS device is based on the concept of polymer-free drug elution.<\/p>\n","protected":false},"author":24,"featured_media":710,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[102],"tags":[],"class_list":{"0":"post-4192","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"_links":{"self":[{"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/posts\/4192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/comments?post=4192"}],"version-history":[{"count":1,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/posts\/4192\/revisions"}],"predecessor-version":[{"id":27740,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/posts\/4192\/revisions\/27740"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/salient_g_sections\/710"}],"wp:attachment":[{"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/media?parent=4192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/categories?post=4192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/tags?post=4192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}